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Objective: Distinguishing atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) is often
difﬁcult, and patients with a preoperative diagnosis of AEH are sometimes diagnosed with EC after
hysterectomy. In this study, we assessed the risk factors for EC in patients who underwent total lapa-
roscopic hysterectomy (TLH) with a preoperative diagnosis of AEH.
Patients and methods: We retrospectively analyzed 20 patients with a preoperative diagnosis of AEH
using endometrial cytology, biopsy (fractional and total curettage), and hysteroscopic inspection.
Results: Four of 20 (20%) patients were diagnosed with EC after TLH, all of whom had endometrioid
adenocarcinoma Grade 1 and Stage IA without lymph node metastasis. Four of seven (57%) patients who
were highly suspected of having EC by three diagnostic modalities (cytology, fractional curettage, and by
hysteroscopy) were diagnosed with EC after TLH, whereas none of the 13 without any suspicious ﬁndings
in these examinations were diagnosed with EC (p¼ 0.007 by Fisher's exact test). Hysteroscopic ﬁndings
were positive (suspicious of EC) in six of 11 patients tested, including all four EC patients. However, either
endometrial cytology or fractional curettage alone failed to predict cancer in two EC patients. All four EC
patients were also suspected of having EC by total curettage. Ovarian preservation was performed in 12
(60%) patients. Three of the four EC patients received subsequent surgery, including pelvic
lymphadenectomy.
Conclusion: Careful preoperative examinations, including hysteroscopy, might be useful to evaluate the
risk of EC. Accordingly, we should be still careful about the possibility of overdiagnosis in patients with
AEH.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Atypical endometrial hyperplasia (AEH) is considered a pre-
cancerous stage of endometrial cancer (EC), especially well-icts of interest.
and Gynecology, Faculty of
Bunkyo-ku, Tokyo 113-8655,
).
for Gynecologic Endoscopy and Minim
ses/by-nc-nd/4.0/).differentiated endometrioid endometrial cancer (Grade 1), and
the ratio of concurrent EC and AEH in patients with a prediagnosis
of EC is ~17e52%.1e4 Laparoscopic surgery is broadly applied for
early stage EC patients as well as AEH patients.5,6 However, the type
of surgery is not the same for AEH and EC. Hysterectomy and
bilateral salpingo-oophorectomy (BSO) are considered to be mini-
mally required as a standard surgical treatment in EC, even at Stage
I/II (International Federation of Gynecology and Obstetrics staging),
as ovarian metastasis was reported to be detected in 5e10% of EC
patients with a preoperative evaluation of Stage I/II.7e9 In addition,ally Invasive Therapy. Published by Elsevier Taiwan LLC. This is an open access article under
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agnose the presence or absence of lymph node metastasis. On the
contrary, ovarian preservation can be considered for AEH patients,
especially for premenopausal women, and lymphadenectomy is
unnecessary. The ratio of premenopausal women is ~40e50% in
AEH patients,10,11 and most premenopausal women desire to pre-
serve their ovaries. Thus, appropriate preoperative diagnosis is
important to decide the surgical procedure. However, the patho-
logical diagnosis of AEH and EC (Grade 1) is still challenging, even
when using the samples obtained from total curettage.7 Hysteros-
copy has been reported to be useful for the diagnosis of AEH and EC,
and is anticipated as another diagnostic modality in addition to
pathological diagnosis (cytology of endometrium, endometrial bi-
opsy, and total curettage).12,13 In this study, we retrospectively
analyzed patients with a preoperative diagnosis of AEH, and aimed
to assess the correlation between preoperative diagnosis and
postoperative diagnosis, by focusing on pathologic ﬁndings and
hysteroscopy.Patients and methods
We retrospectively analyzed 20 patients with a preoperative
diagnosis of AEH, who were treated with total laparoscopic hys-
terectomy (TLH) at the University of Tokyo Hospital, Tokyo, Japan
from 2013 to 2015. The study was performed under the approval of
the Institutional Review Board of our hospital and with written
informed consent. The AEH patients who underwent laparotomy
due to severe obesity (body mass index > 32) and/or enlargement
of the uterus, were not included in this study. Eight of 20 (40%)
patients received BSO, and 12 patients (60%) received bilateral
salpingectomy with ovarian preservation. All patients received
cytologic evaluation of the endometrium and fractional endome-
trial curettage, followed by total endometrial curettage (dilatation
of the cervix and curettage). Hysteroscopy was performed in 11Table 1
Patient characteristics, ﬁndings of each examination, and ﬁnal diagnosis in 20 patients w
No. Age Gravidity Parity Menopause BMI Cytologyb Biopsy Total
curettage
1 45 0 0 e <25 Suspicious AEH AEH
2 51 4 2 e <25 Suspicious AEH AEH
3 37 1 0 e <25 Negative AEH AEH
4 49 0 0 e 29 Suspicious AEH AEH
5 47 4 2 e 25.7 Suspicious AEH AEH
6 47 0 0 e 31.2 Suspicious AEH AEH
7 48 3 2 e 27.5 Suspicious AEH AEH
8 46 0 0 e 26 Negative AEH AEH
9 43 1 1 e <25 Suspicious AEH AEH
10 45 1 0 e <25 Suspicious AEH AEH
11 43 0 0 e <25 Positive AEH AEH
12 51 3 1 e <25 Suspicious AEH AEH
13 54 3 3 51 <25 Negative AEH suspected AEH
14 46 0 0 e <25 Suspicious AEH AEH
15 59 0 0 55 25.2 Suspicious AEH AEH
16 47 2 2 e <25 Positive EC strongly
suspected
AEH
17 55 2 2 50 <25 Positive AEH or more AEH
18 50 0 0 e 25.8 Positive AEH or more AEH or
more
19 59 3 3 50 <25 Negative EMH (without
atypia)
AEH or
more
20 31 0 0 e <25 Suspicious AEH AEH or
more
AEH¼ atypical endometrial hyperplasia; BMI¼ body mass index; BSO¼ bilateral salping
PLA¼ pelvic lymphadenectomy; TCR¼ transcervical resection.
a Null entries are either not analyzed (for examinations) or not observed (for uterine
b Negative (no atypical endometrius), suspicious (atypical endometrial cells), and posi
c AEH likely (protruding lesion with mild to moderate atypical vessels); EC likely (pappatients (55%), and transcervical resection was performed in ﬁve
(25%) patients. Thickness of the endometrium was evaluated with
magnetic resonance imaging and transvaginal ultrasonography.
Final diagnosis was determined with pathological ﬁndings of the
resected uterus. Nonatypical hyperplasia remaining in the hyster-
ectomy specimen was diagnosed as AEH. For EC patients, we per-
formed subsequent surgery with oophorectomy (if preserved
during the initial surgery) and pelvic lymphadenectomy, except for
one case who had received TLH and BSO and declined to receive
lymphadenectomy. Fisher’s exact test was used to evaluate the risk
factors between the two groups of AEH and EC (ﬁnal diagnosis). The
p-values were considered to be signiﬁcant at p < 0.05.Results
The ﬁnal diagnosis was EC in four (20%) and AEH in 16 (80%) of
the 20 patients. All four patients with ECwere diagnosed as Stage IA
with well-differentiated adenocarcinoma (Grade 1). Three of four
patients received pelvic lymphadenectomy, which revealed no
lymph nodemetastasis. The patient characteristics, prepathological
and postpathological diagnosis, and histeroscopic ﬁndings are lis-
ted in Table 1. The size of the uterus and absence of myometrial
invasion were conﬁrmed using magnetic resonance imaging in all
20 patients. The median age of the 20 patients was 47.6 years.
Among 12 patients with ovarian preservation, one (8.3%) was
diagnosed as EC, and 11 were diagnosed as AEH. In cytology of the
endometrium before surgery, four (20%) patients were diagnosed
as positive (EC was suggested), 11 (50%) patients were as suspicious
(with atypical endometrial epithelium), and ﬁve (25%) patients
were as negative (Table 1). By fractional endometrial curettage,
three (15%) patients were diagnosed as suspicious of EC (unable to
discriminate AEH and EC), 14 (70%) patients were as AEH, and two
(10%) patients as endometrial hyperplasia, complex, or suspicious
of AEH (Table 1). By total curettage (5 patients received concurrentith a prediagnosis of atypical endometrial hyperplasia (AEH).a
Hysteroscopyc Em
(mm)
Ovaries Uterine
ﬁborid
TCR Final
diagnosis
Sequential
surgery
10 Preserved AEH
AEH likely 10 Preserved 4 cm AEH
7 Preserved 2 cm AEH
5 Preserved 4 cm AEH
AEH likely 6 Preserved Done AEH
AEH likely 10 Preserved AEH
13 Preserved AEH
15 Preserved 3 cm AEH
14 Preserved 3 cm AEH
16 Preserved AEH
7 Preserved AEH
AEH likely 8 BSO 5 cm Done AEH
AEH likely 5 BSO 2 cm Done AEH
15 BSO 2 cm AEH
EC likely 16 BSO 3 cm Done AEH
EC likely 5 BSO AEH
EC likely 10 BSO G1, Ia PLA
EC likely 8 BSO 3 cm Done G1, Ia PLA
EC likely 20 BSO G1, Ia
EC likely 12 Preserved G1, Ia Laparo-BSO þ PLA
o-oophorectomy; EC¼ endometrial cancer; EMH¼ extramedullary hematopoiesis;
ﬁbroids).
tive (adenocarcinomy, highly suspected cells).
illary, irregular-shaped, and solid lesion with severe atypical vessels).
Figure 1. Microscopic ﬁndings of one typical patient (#17), whose prediagnosis is atypical endometrial hyperplasia and ﬁnal diagnosis is endometrial cancer: (A) microscopic
features (high power) by total curettage (the glands are irregular-shaped, and closely packed, but stromal tissue exists among the atypical glands). This was diagnosed as atypical
endometrial hyperplasia with possibility of concurrent endometrial cancer; (B) microscopic features (high power) of the specimen obtained by total laparoscopic hysterectomy (a
back-to-back glandular structure was observed with stromal disappearance). Solid growth was < 5%, and was diagnosed as endometrioid adenocarcinoma, Grade 1.
Figure 2. Hysteroscopic ﬁndings of two patients, whose prediagnosis was atypical endometrial hyperplasia and ﬁnal diagnosis was endometrial cancer: (A) hysteroscopic features
of patient #19 in Table 1. Irregular-shaped, broad solid lesion with atypical vascularization was observed, which was suspected of endometrial cancer; (B) hysteroscopic features of
patient #20 in Table 1. Papillary solid lesions were spread in endometrial cavity with intermittent atypical vessels.
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Table 2
Correlation between clinicopathological characteristics and ﬁnal diagnosis.
AEH Endometrial cancer p
Age
<50 12 1
50 4 3 0.10
Gravidity
0 7 2
1 9 2 1.0
Parity
0 9 2
1 7 2 1.0
BMI
<25 10 3
>25 6 1 1.0
Thickness of endometrium
<10 7 1
>10 9 3 0.62
Cytology
Negative/suspicious 14 2
Positive 2 2 0.16
Biopsy (fractional)
AEH likely 15 2
Cancer suspected 1 2 0.087
Hysteroscopy
AEH likely 5 0
Cancer highly suspected 2 4 0.022
Presence of risk factorsa
Negative 13 0
Positive 3 4 0.007
Biopsy (fractional and Total curettage)
AEH likely 15 0
Cancer suspected 1 4 <0.001
AEH¼ atypical endometrial hyperplasia; BMI¼ body mass index.
a Risk factors by cytology, fractional biopsy, and hysteroscopy.
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diagnosed as AEH, and three patients were as suspicious of EC
(unable to discriminate AEH and EC; Table 1). Pathologically, AEH is
characterized with atypical glands consisting of dyspolaric cells,
eosinophilic cytoplasm, and rounded, enlarged nuclei with prom-
inent nucleoli.14 The histological ﬁndings of one case, in which EC
cannot be ruled out and diagnosed as EC after hysterectomy, are
shown in Figure 1. In the specimen of total curettage, the irregularly
shaped glands are closely packed; however, no deﬁnitive stromal
invasion was observed (EC was suspected but not deﬁnitely diag-
nosed; Figure 1A). In the specimen of TLH, back-to-back glands
were clearly observed with stromal disappearance, which was
diagnosed as EC (Figure 1B). Among 11 patients who received
hysteroscopic inspection, ﬁve (45%) showed papillary protruding
lesions with atypical vessels, which suggest the possibility of EC
(especially Grade 1) and considered as positive in this study
(Figure 2).
Next, we analyzed the association between clinical character-
istics and ﬁnal diagnosis (risk of EC). Twelve of 16 (75%) AEH pa-
tients were younger than 50 years, while one of four with EC were
younger than 50 years (p¼ 0.10; Table 2). Gravidity, parity, body
mass index, and thickness of the endometriumwere not associated
with the risk of EC (Table 2). Endometrial cytology alone or frac-
tional curettage alone was not signiﬁcantly associated with the risk
of EC in this setting (p¼ 0.16 and p¼ 0.087, respectively; Table 2).
Hysteroscopic ﬁndings with papillary swollen lesions with atypical
vessels were signiﬁcantly associated with the risk of EC (p¼ 0.022;
Table 2). By combining these three examinations, the presence of
any risk factors was also associated with the risk of EC (p¼ 0.007).
By fractional and total curettage, all four patients with EC were
suspected for EC, whereas only one (6%) of 16 AEH patients were
suspected for EC (p< 0.001).Discussion
Laparoscopic surgery is broadly performed in patients with AEH
and early stage EC with Grade 1. Although laparoscopic surgery is
less invasive than laparotomy,5,15,16 the difﬁculty in the differential
diagnosis of AEH and well-differentiated endometrioid EC may
result in enforced secondary surgery or overtreatment. In this
study, we focused on patients with preoperatively diagnosed AEH
(after total curettage), and examined what kind of ﬁndings are
associated with a ﬁnal diagnosis of EC.
In this study, four out of 20 patients (20%) with preoperatively
diagnosed AEH had a ﬁnal diagnosis of EC (Grade 1). Our data are in
agreement with previous reports that show 6e48% of patients with
a preoperative diagnosis of AEH have concurrent EC.4 These data
support the difﬁculty and limitation of preoperative differential
diagnosis of AEH and EC.14 However, the presence of EC was sus-
pected in all four cases where EC was diagnosed using histopath-
ological examination. Moreover, hysteroscopy indicated the
possibility of EC in all these patients, which revealed the ﬁndings of
papillary protruding lesions with atypical vessels. The usefulness of
hysteroscopy for EC has been reported.12,17 Therefore, by using a
combination of pathological and hysteroscopic ﬁndings, the risk of
EC could be evaluated in patients with a preoperative diagnosis of
AEH. Intraoperative diagnosis using frozen sections of the uterus
might be informative for diagnosis of AEH and EC; however, the risk
of EC still remains in patients with AEH.18 In addition, we should be
aware of the falseepositive risk in both the preoperative and
intraoperative pathological examination,19 and be aware of the
variation of diagnosis among pathologists. The risk of concomitant
malignancy of the endometrium and ovaries should be also
considered, even in AEH patients who desire ovarian preservation.
It was reported that 26 of 102 (25%) women younger than 45 years
who underwent hysterectomy for EC were found to have coexisting
epithelial ovarian cancer (EOC), and four women lacked any
abnormal intraoperative ﬁndings in the ovaries.20 The overall rate
of coexisting EOC in EC patients is ~7%, with the ratio at 6.3% in
patients younger than 45 years and 8.4% in those older than 45
years.21 Coexistence of AEH was also reported in EOC patients.22
Therefore, the potential risk of latent EOC requires careful consid-
eration for patients undergoing hysterectomy to treat endometrial
malignancy. Lymph nodemetastasis is reported to be low (1.3e2.0%
in Stage 1A and Grade 1 EC) and the effect of PLA on prognosis is
still under debate.23e25 If patients do not wish to receive (or phy-
sicians do not plan to perform) PLA, TLH and BSO might be a
favorable option for patients with a preoperative diagnosis of AEH
and high risk of EC, even in premenopausal women. This may allow
patients to avoid an additional surgery (oophorectomy).
This study has several limitations. Firstly, the sample size is
small and hysteroscopic inspection was not performed for all pa-
tients. Secondly, interpretation of hysteroscopic ﬁndings may vary
among investigators. Thirdly, the data in this study may not apply
to patients who received total abdominal hysterectomy because the
preoperative diagnosis may be more difﬁcult in those patients due
to enlargement and/or deformation of the endometrial cavity.
In conclusion, although the preoperative differential diagnosis
of AEH and EC (Grade 1) is still challenging, the risk of EC may be
evaluated by a combination of pathological and hysteroscopic
ﬁndings. Further study is warranted to improve the preoperative
diagnosis and contribute to avoiding repetitive surgery by the
postoperative diagnosis.
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